CRYSTEC PHARMA

crystec-pharma-logo

CrystecPharma is a crystal and particle engineering company applying proprietary modified supercritical fluid (SCF) technologies to improve the performance of medicines. Our technology enables drug molecules to be crystallised in new forms and novel particles to be manufactured in ways that greatly enhance their therapeutic performance. Crystec has an enabling platform which can be applied to small and large molecules, to optimise a range of medicine dosage forms (e.g. oral, inhaled, intranasal,... subcutaneous, sublingual). Crystec works with the global pharmaceutical and health care industry to solve drug particle formation, formulation and process challenges. We are also developing our own innovative therapies in important areas of unmet clinical need, including womenโ€™s health, urology and treating respiratory disease. Crystecโ€™s proprietary โ€˜mSASโ€™ (modified Supercritical Anti-Solvent) drug delivery technology is enabled by a highly efficient, stable and fully scalable manufacturing process and is approved by regulatory authorities. The mSAS platform creates unique opportunities to improve medicines in ways that can transform the quality of life for many patients.

#People #Website #More

CRYSTEC PHARMA

Social Links:

Industry:
Biopharma Biotechnology Health Care Manufacturing Pharmaceutical

Address:
Bradford, Somerset, United Kingdom

Country:
United Kingdom

Website Url:
http://www.crystecpharma.com

Status:
Active

Contact:
+44 (0)1274 235592

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Microsoft Exchange Online Organization Schema Office 365 Mail AJAX Libraries API


Current Employees Featured

paul-thorning_image

Paul Thorning
Paul Thorning Co-founder and Chief Executive Officer @ Crystec Pharma
Co-founder and Chief Executive Officer
2007-09-01

peter-odonovan_image

Peter O&s;Donovan
Peter O'Donovan Chief Medical Officer @ Crystec Pharma
Chief Medical Officer

peter-york_image

Peter York
Peter York Co-founder and Chief Scientist @ Crystec Pharma
Co-founder and Chief Scientist

qun-shao_image

Qun Shao
Qun Shao Chief Operations Officer and Co-founder @ Crystec Pharma
Chief Operations Officer and Co-founder
2007-10-01

Founder


paul-thorning_image

Paul Thorning

peter-york_image

Peter York

qun-shao_image

Qun Shao

Official Site Inspections

http://www.crystecpharma.com Semrush global rank: 760.77 K Semrush visits lastest month: 52.59 K

  • Host name: grh44.myukcloud.com
  • IP address: 85.92.70.80
  • Location: United Kingdom
  • Latitude: 51.4964
  • Longitude: -0.1224
  • Timezone: Europe/London

Loading ...

More informations about "Crystec Pharma"

About Crystec - Crystec Limited (CrystecPharma)

About Crystec About Us CrystecPharma is a crystal and particle engineering company applying proprietary modified supercritical fluid (SCF) technologies to improve the performance of medicines. Our technology enables drug โ€ฆSee details»

Crystec Pharma - Crunchbase Company Profile & Funding

CrystecPharma is a crystal and particle engineering company applying proprietary modified supercritical fluid (SCF) technologies to improve the performance of medicines. Our โ€ฆSee details»

CrystecPharma - LinkedIn

CrystecPharma | 4,225 followers on LinkedIn. Performance in every particle | Crystec Pharma is focused on applying supercritical fluid technology to improve the performance of medicines. We ...See details»

Crystec Pharma - VentureRadar

CrystecPharma is a crystal and particle engineering company applying proprietary modified supercritical fluid (SCF) technologies to improve the performance of medicines. Our โ€ฆSee details»

Crystec Pharma Company Profile 2024: Valuation, โ€ฆ

Information on valuation, funding, cap tables, investors, and executives for Crystec Pharma. Use the PitchBook Platform to explore the full profile.See details»

Crystec Pharma - Craft

CrystecPharma is a company that provides crystal and particle engineering solutions to the pharmaceutical industry. It is focused on applying supercritical fluid technology to improve the โ€ฆSee details»

How We Operate โ€“ Crystec Limited (CrystecPharma)

Crystec is investing in the development of its own portfolio of improved or repurposed generic products. Each of these products is exploiting specific advantages of mSAS ® technology, whether in designing particles capable of โ€ฆSee details»

CrystecPharma Ltd.: Contact Details and Business Profile

CrystecPharma Ltd. is a Pharmaceuticals, Drug Manufacturing & Research, and Biopharma company located in Bradford, England with $4.00 Million in revenue and 17 employees. Find โ€ฆSee details»

About Us - CrystecPharma

CrystecPharma is a crystal and particle engineering company applying proprietary modified supercritical fluid (SCF) technologies to improve the performance of medicines. ... has โ€ฆSee details»

Crystec Pharma | Scientist.com

If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the โ€ฆSee details»

CrystecPharma - Overview, News & Similar companies - ZoomInfo

Nov 5, 2019 CrystecPharma is a crystal and particle engineering company applying proprietary modified supercritical fluid (SCF) technologies to improve the performance of medicines. Our โ€ฆSee details»

CrystecPharma | ้ข†่‹ฑ - ้ข†่‹ฑ (ไธญๅ›ฝ)

CrystecPharma | ๅœจ้ข†่‹ฑไธŠๆœ‰ 4,031 ไฝๅ…ณๆณจ่€…ใ€‚Performance in every particle | Crystec Pharma is focused on applying supercritical fluid technology to improve the performance of medicines. โ€ฆSee details»

Our History - Crystec Limited (CrystecPharma)

Our History Crystec establishes Inhalis Therapeutics SA, a Swiss joint venture with SignalRX Pharmaceuticals and ADYA Sagl to develop a novel inhaled treatment for Idiopathic โ€ฆSee details»

CrystecPharma - Company Profile & Staff Directory - ContactOut

Crystec Pharma is focused on applying supercritical fluid technology to improve the performance of medicines. We provide crystal and particle engineering solutions to the pharmaceutical โ€ฆSee details»

CrystecPharma Company Overview, Contact Details & Competitors โ€ฆ

Industry Recognition The recognition received by CrystecPharma, such as the Making Pharmaceuticals Award for Innovation in Manufacturing, showcases the company's โ€ฆSee details»

A collaboration to enhance the delivery of biotherapeutics and โ€ฆ

Oct 19, 2021 www.crystecpharma.com For further information please contact: - Emily Bevis, Business Development Manager ([email protected]) - Angeles Heer, Tech โ€ฆSee details»

Solutions โ€“ Crystec Limited (CrystecPharma)

40% of marketed drugs and up to 90% of those in development exhibit poor solubility. mSAS ® provides different ways to address this challenge, including through increasing surface area, โ€ฆSee details»

Collaboration Between CrystecPharma and Iconovo Aims to โ€ฆ

Nov 8, 2019 CrystecPharma specializes in a technique called modified supercritical anti-solvent (mSAS) technology to engineer particles with improved characteristics. In mSAS, the โ€ฆSee details»

Pipeline - Crystec Limited (CrystecPharma)

Crystec Development Pipeline In addition to enhancing the performance of client products, we also apply our mSAS® technology platform in non-competing areas to Crystecโ€™s own in-house โ€ฆSee details»